These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6446394)

  • 1. Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.
    Nishiura T
    Clin Ther; 1980; 3(Spec Issue):190-205. PubMed ID: 6446394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with cefoperazone in the field of internal medicine in Japan.
    Mashimo K; Kunii O
    Clin Ther; 1980; 3(Spec Issue):159-72. PubMed ID: 6446392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin in the management of complicated urinary tract infections, including prostatitis.
    Cox CE
    Am J Med; 1989 Dec; 87(6C):61S-68S. PubMed ID: 2690622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial of HAPA-B in complicated urinary tract infections].
    Kamiryo Y; Kato M; Sanefuji T; Hirao H
    Hinyokika Kiyo; 1986 Sep; 32(9):1379-85. PubMed ID: 3101447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter clinical trials of cefoperazone in Japan.
    Saito A; Ueda Y
    Clin Ther; 1984; 7(1):49-59. PubMed ID: 6394129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK; Christensen GD; Hester MG; Ling FW; Pate JW; Rosenberg EW; Anderson GD; Bisno AL
    Clin Ther; 1981; 4(3):164-74. PubMed ID: 6458360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T; Belmega G; Lode H; Kemmerich B; Dzwillo G; Koeppe P; Wagner J
    Med Klin; 1981 Feb; 76(4):102-6, 70. PubMed ID: 6452567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
    Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
    Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro action and clinical use of indanyl carbenicillin].
    Fontana G; Laudi M; Sesia G; Savoia D; Cauda F
    Minerva Urol; 1976; 28(6):285-8. PubMed ID: 827680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with T-2588 in complicated urinary tract infections].
    Fukatsu H; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y; Waki M; Takamura T; Hiraiwa S; Yamada Y; Muramatsu T
    Hinyokika Kiyo; 1986 Jul; 32(7):1061-8. PubMed ID: 3776768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indanyl Carbenicillin in the treatment of urinary tract infections due to difficult urological organisms (author's transl)].
    Popa G; Nuri M; Peters HJ
    Med Klin; 1976 Jan; 71(3):104-9. PubMed ID: 765706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipseudomonal activities of new cephem antibiotics].
    Ohkoshi M
    Hinyokika Kiyo; 1984 Apr; 30(4):437-48. PubMed ID: 6435413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
    Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
    Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical-pharmacological study of the new semi-synthetic penicillin preparation, carbenicillin, in urologic patients. Relations between blood and tissue concentration of carbenicillin].
    Iván E; Földi J; Arr M; Molnár I; Biró L
    Z Urol Nephrol; 1970 Apr; 63(4):241-6. PubMed ID: 4943703
    [No Abstract]   [Full Text] [Related]  

  • 18. Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
    Iversen P; Madsen PO
    Clin Ther; 1981; 4(4):302-7. PubMed ID: 7037184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of Claforan (CTX) in aged patients with chronic complicated urinary tract infections].
    Washida H; Tsugaya M; Hirao N; Hachisuka Y
    Hinyokika Kiyo; 1984 Jan; 30(1):121-9. PubMed ID: 6328960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective treatment of urinary tract infection with carbenicillin].
    Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
    Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.